Concourse Financial Group Securities, Inc. Anebulo Pharmaceuticals, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.3MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$14.7 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$2.88 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$2.4 Million0.66% of portfolio
-
Morgan Stanley New York, NY420KShares$398,9940.0% of portfolio
-
Lvw Advisors, LLC350KShares$332,1360.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $24.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...